2020
Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study
McGee EE, Kim CH, Wang M, Spiegelman D, Stover DG, Heng YJ, Collins LC, Baker GM, Farvid MS, Schedin P, Jindal S, Tamimi RM, Eliassen AH. Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study. Breast Cancer Research 2020, 22: 78. PMID: 32698885, PMCID: PMC7374956, DOI: 10.1186/s13058-020-01316-4.Peer-Reviewed Original ResearchConceptsBreast cancer riskImmuno-inflammatory markersErythrocyte membrane fatty acidsCase-control studyTumor tissue expressionFatty acid synthaseCancer riskTrans fatty acidsExpression subtypesOdds ratioSpecific fatty acidsLogistic regressionHealth Study IITumor tissue blocksMembrane fatty acidsFatty acidsUnconditional logistic regressionConfidence intervalsTissue expressionT cell functionPolytomous logistic regressionAcid synthaseTumor CD4Potential confoundersTumor expression
1998
Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
Hisada M, Okayama A, Shioiri S, Spiegelman D, Stuver S, Mueller N. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998, 92: 3557-61. PMID: 9808547, DOI: 10.1182/blood.v92.10.3557.422k09_3557_3561.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge of OnsetAgedAged, 80 and overBiomarkers, TumorCarrier StateCohort StudiesFemaleGene Products, taxHTLV-I AntibodiesHTLV-I InfectionsHuman T-lymphotropic virus 1HumansJapanLeukemia-Lymphoma, Adult T-CellMaleMiddle AgedNeoplastic Stem CellsProspective StudiesRisk FactorsSmokingT-LymphocytesConceptsAdult T-cell leukemiaHTLV-I carriersT-cell leukemiaAsymptomatic HTLV-I carriersHuman T-lymphotropic virus type IHuman T-lymphotropic virus type I.Miyazaki Cohort StudyHTLV-I antibodiesVirus type IAbnormal lymphocytesCohort studyViral markersATL diagnosisRisk factorsLow prevalenceFlower cellsATL casesGreater riskHTLVAntibodiesPositive controlType I.LeukemiaRegulatory proteinsType I